Jörgen Lehmann
Danish-Swedish physician and chemist · Sweden · On the map · Doctors · Lived 1898 to 1989 · aged 91
Jörgen Erik Lehmann was a Danish-Swedish physician and clinical chemist best known for his discovery in the 1940s that para-amino salicylic acid (PAS) would make an excellent orally-available tuberculosis therapy.
Jörgen Lehmann is read about 2 times a day, in 5 languages.
A typical day, 30 days to 24 September 2026
The middle day of the days counted, so one week of news cannot move it. The line under it is the last 60 days, one point a day.
Something wrong?Media & music
Photos 1
Awards
About this person
PAS was, together with streptomycin, the first efficacious anti-microbial therapy for tuberculosis and remained in clinical use for several decades. The exclusion of him as a Nobel laureate in 1952 was highly controversial, and the discoverer of streptomycin, Selman Waksman, was the sole recipient of the Nobel Prize in Physiology or Medicine that year. In 1941, Lehmann also developed the anti-coagulant dicumarol, which is used for the prevention of blood clots and in the treatment of deep venous thrombosis.
